First Wave BioPharma Announces First Patient Screened for Phase 2 SPAN Adrulipase Trial in Cystic Fibrosis February 2, 2023
Adial Pharmaceuticals Enters Into Option Agreement for Sale of Purnovate Assets to Adenomed February 1, 2023